Cargando…

Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study

Background: Traditional Chinese medicine (TCM), a main form of complementary and alternative medicine provides a potential possibility for demyelinating disease of the central nervous system (DDC) management and has been applied in considerable amounts of patients with this disorder. Nevertheless, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Zhang, Chi, Xie, Yao, Zhou, Li, Guo, Li, Li, Bin, Jia, Zhen, Zhang, Jingze, Sugimoto, Kazuo, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744113/
https://www.ncbi.nlm.nih.gov/pubmed/36518667
http://dx.doi.org/10.3389/fphar.2022.981300
_version_ 1784848849687281664
author Liu, Jia
Zhang, Chi
Xie, Yao
Zhou, Li
Guo, Li
Li, Bin
Jia, Zhen
Zhang, Jingze
Sugimoto, Kazuo
Gao, Ying
author_facet Liu, Jia
Zhang, Chi
Xie, Yao
Zhou, Li
Guo, Li
Li, Bin
Jia, Zhen
Zhang, Jingze
Sugimoto, Kazuo
Gao, Ying
author_sort Liu, Jia
collection PubMed
description Background: Traditional Chinese medicine (TCM), a main form of complementary and alternative medicine provides a potential possibility for demyelinating disease of the central nervous system (DDC) management and has been applied in considerable amounts of patients with this disorder. Nevertheless, powerful real-world evidences regarding the epidemiological and clinical characteristics, safety, and outcomes of TCM in DDC are lacking. The primary objective of the Demyelinating Diseases of the Central Nervous System Registry for Patients with Traditional Chinese Medicine (DATE-TCM) is to create an organized multicenter data collection structure to define integrative characteristics of DDC patients treated with TCM in an endeavor to fill these knowledge gaps to better inform clinical care and health policy. Method: This study provides a prospective and voluntary registry by using a web-based system. Baseline data will be recorded and subsequently regular follow-up visits will be implemented every 3–6 months for a total of 5 years. The primary outcome is Annualized Aggregate Relapse Rate at 5-year follow-up. Results: DATE-TCM is currently designed to capture the multidimensional (epidemiologic, demographic, clinical, etc.) features of DDC patients receiving TCM treatment, the type and long-term safety and efficacy of TCM intervenes in the DDC populations, as well as the interaction of TCM treatments and disease modifying therapies in the management of DDC, aiming to include 2000 eligible adult DDC patients with TCM intervenes from 35 participating centers, covering 77.4% of provincial administrative regions of mainland China. Conclusion: DATE-TCM is the first, largest, most geographically extensive, and standard registry-based observational study that systematically document the real-world data regarding the TCM application in the DDC populations, which will be extraordinarily important for clarifying the comprehensive characteristics and outcomes of TCM in DDC, further shed light on standardizing and optimizing the TCM measures for DDC management and establishing evidence-based clinical practice guidelines for TCM application in DDC.
format Online
Article
Text
id pubmed-9744113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97441132022-12-13 Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study Liu, Jia Zhang, Chi Xie, Yao Zhou, Li Guo, Li Li, Bin Jia, Zhen Zhang, Jingze Sugimoto, Kazuo Gao, Ying Front Pharmacol Pharmacology Background: Traditional Chinese medicine (TCM), a main form of complementary and alternative medicine provides a potential possibility for demyelinating disease of the central nervous system (DDC) management and has been applied in considerable amounts of patients with this disorder. Nevertheless, powerful real-world evidences regarding the epidemiological and clinical characteristics, safety, and outcomes of TCM in DDC are lacking. The primary objective of the Demyelinating Diseases of the Central Nervous System Registry for Patients with Traditional Chinese Medicine (DATE-TCM) is to create an organized multicenter data collection structure to define integrative characteristics of DDC patients treated with TCM in an endeavor to fill these knowledge gaps to better inform clinical care and health policy. Method: This study provides a prospective and voluntary registry by using a web-based system. Baseline data will be recorded and subsequently regular follow-up visits will be implemented every 3–6 months for a total of 5 years. The primary outcome is Annualized Aggregate Relapse Rate at 5-year follow-up. Results: DATE-TCM is currently designed to capture the multidimensional (epidemiologic, demographic, clinical, etc.) features of DDC patients receiving TCM treatment, the type and long-term safety and efficacy of TCM intervenes in the DDC populations, as well as the interaction of TCM treatments and disease modifying therapies in the management of DDC, aiming to include 2000 eligible adult DDC patients with TCM intervenes from 35 participating centers, covering 77.4% of provincial administrative regions of mainland China. Conclusion: DATE-TCM is the first, largest, most geographically extensive, and standard registry-based observational study that systematically document the real-world data regarding the TCM application in the DDC populations, which will be extraordinarily important for clarifying the comprehensive characteristics and outcomes of TCM in DDC, further shed light on standardizing and optimizing the TCM measures for DDC management and establishing evidence-based clinical practice guidelines for TCM application in DDC. Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC9744113/ /pubmed/36518667 http://dx.doi.org/10.3389/fphar.2022.981300 Text en Copyright © 2022 Liu, Zhang, Xie, Zhou, Guo, Li, Jia, Zhang, Sugimoto and Gao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Jia
Zhang, Chi
Xie, Yao
Zhou, Li
Guo, Li
Li, Bin
Jia, Zhen
Zhang, Jingze
Sugimoto, Kazuo
Gao, Ying
Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
title Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
title_full Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
title_fullStr Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
title_full_unstemmed Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
title_short Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
title_sort demyelinating diseases of the central nervous system registry for patients with traditional chinese medicine: rationale and design of a prospective, multicenter, observational study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744113/
https://www.ncbi.nlm.nih.gov/pubmed/36518667
http://dx.doi.org/10.3389/fphar.2022.981300
work_keys_str_mv AT liujia demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT zhangchi demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT xieyao demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT zhouli demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT guoli demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT libin demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT jiazhen demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT zhangjingze demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT sugimotokazuo demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy
AT gaoying demyelinatingdiseasesofthecentralnervoussystemregistryforpatientswithtraditionalchinesemedicinerationaleanddesignofaprospectivemulticenterobservationalstudy